Concept to IND
Tailored to Your Needs

Where discovery meets IND, one partner for preclinical excellence
Who we are

Medicilon is committed to support our partners every step along their unique drug discovery journey

From precision chemical synthesis to preclinical advancements – ADME/DMPK, pharmacology, and safety – we deliver holistic solutions tailored to your innovations.

Our history

Transforming global drug discovery by empowering pharmaceutical innovators

Years of Experience

20+

IND-Approved Projects

500+

DMPK/ADME Studies

>10,000 compounds/ year

Our Services

Unified expertise, building a path to your success

Combining advanced capabilities in biology, chemistry, and preclinical research, we deliver tailored services that take you seamlessly from drug discovery to IND.

Drug Discovery

Driving drug discovery through unrivaled chemical synthesis and integrated biologics.

CMC Development

From process development to GMP manufacturing – for a seamless path to IND.

Preclinical Research

Where ADME/DMPK and Toxicology intersect to de-risk programs and accelerate clinical progress. Non-GLP and GLP studies ensure flexibility for early research and compliance for regulatory submission.

ADME/DMPK
Optimize drug candidates with comprehensive DMPK/ADME insights.
Pharmacodynamics (PD)
Uncover drug efficacy and mechanisms with expert pharmacodynamics solutions.
Safety Assessment
Ensure therapeutic safety with comprehensive and reliable toxicology services.
Our promises

Expertise, innovation, and partnership

Innovation First

Harnessing cutting-edge technology to solve complex challenges.

Unwavering Dedication

Driving success through respect, collaboration, and passion.

Client-Centric Excellence

Setting the gold standard in quality, speed, compliance, and IP protection.

Mutual Success

Building lasting partnerships rooted in trust and shared goals

Tailored preclinical solutions to propel your innovations from discovery to clinical milestones

Contact Medicilon

Name
Address

Search Medicilon

Medicilon Appoints Dr. Jian Ge as EVP of Preclinical Research Division

Medicilon Supports Moon Biotech’s Groundbreaking MNO-863 Probiotic Drug – Achieves Nearly 10% Weight Loss in 4 Weeks and Secures Dual Clinical Trial Trial Approvals

Zero Defects! Medicilon Supports MeiJi BioPharma’s Oral Paclitaxel Soft Capsule in Gaining FDA IND Approval